Davidson Kempner Capital Management’s AEON Biopharma Inc AEON.WS Stock Holding History

Davidson Kempner Capital Management’s Portfolio AEON.WS Stock Details AEON.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-366,671	Closed	-$532K	–	323
2024 Q1	$532K	Hold	366,671	–	–	0.01%	174
2023 Q4	$36.6K	Hold	366,671	–	–	﹤0.01%	177
2023 Q3	$55K	Hold	366,671	–	–	﹤0.01%	180
2023 Q2	$27.5K	Hold	366,671	–	–	﹤0.01%	213
2023 Q1	$18.7K	Hold	366,671	–	–	﹤0.01%	296
2022 Q4	$11K	Hold	366,671	–	–	﹤0.01%	357
2022 Q3	$18K	Hold	366,671	–	–	﹤0.01%	426
2022 Q2	$55K	Hold	366,671	–	–	﹤0.01%	386
2022 Q1	$103K	Hold	366,671	–	–	﹤0.01%	435
2021 Q4	$187K	Hold	366,671	–	–	﹤0.01%	421
2021 Q3	$205K	Hold	366,671	–	–	﹤0.01%	382
2021 Q2	$367K	Buy	+366,671	New	+$278K	﹤0.01%	433

Davidson Kempner Capital Management's AEON.WS Position: Q2 2024 in Review

Davidson Kempner Capital Management sold out of AEON Biopharma Inc (AEON.WS) in Q2 2024, closing a stake of 366,671 shares — an estimated $532K sold.

Davidson Kempner Capital Management first reported a position in AEON.WS in Q2 2021 and held it in 12 quarters. The position peaked at $532K in Q1 2024. 0 funds tracked by Wall St. Rank hold AEON.WS as of Q2 2024.

Davidson Kempner Capital Management reported no remaining AEON Biopharma Inc position as of Q2 2024 after selling out during the quarter.
Davidson Kempner Capital Management sold 366,671 AEON Biopharma Inc shares in Q2 2024, an estimated $532K.
Davidson Kempner Capital Management first reported a position in AEON Biopharma Inc in Q2 2021 and held it in 12 quarters.
Davidson Kempner Capital Management's AEON Biopharma Inc position peaked at $532K in Q1 2024.
0 funds tracked by Wall St. Rank held AEON Biopharma Inc as of Q2 2024.

Based on Davidson Kempner Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.